Skip to main content
Equibles

SDMHF · Sartorius Stedim Biotech S.A. · Webcasts, Transcripts & Audio

Track SDMHF — free

Use SDMHF with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SDMHF.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$248.00 -6.56 (-2.58%) At close · Oct 30 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$24.13B
Shares
97.31M
Volume · Oct 30 1800 Avg daily vol (3M) 5012

Sartorius Stedim Biotech S.A. Webcasts

Earnings calls, investor updates, investor days and conferences for Sartorius Stedim Biotech S.A. (SDMHF), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)

Embed Sartorius Stedim Biotech S.A. earnings calls on your site

Pick a widget, match your page, then paste the code where it should appear.

Widget
Theme
Accent color Pro

Match your site's colors with Pro. The Equibles credit stays on every plan.

Embed code 

                    
The widget credits Equibles and keeps the link below it on every plan.

                

            


            

                Preview
                
            

        

        
    

    




    
    
    


        

    

        

            

                Key facts
                    
                        CIK
                        1794363
                    
                    
                    
                         Visit website
                        
                    
                    
                         Investor relations